Literature DB >> 18611920

The genetics of SLE: an update in the light of genome-wide association studies.

B Rhodes1, T J Vyse.   

Abstract

Understanding the pathogenesis of SLE remains a considerable challenge. Multiple abnormalities of both the innate and adaptive immune system have been described and, furthermore, immunological dysfunction precedes clinical presentation by many years. There is a strong genetic basis to SLE, which means that genetic studies can play a key role in furthering our understanding of this disease. Since susceptibility variants are present from birth and are unaffected by the course of the disease, or by its treatment, genetic analysis is, perhaps uniquely, capable of identifying fundamental, causative, disease mechanisms. Over the last 12 months, there has been a staggering increase in our understanding of SLE genetics. We have seen the identification of new and important SLE susceptibility genes through candidate gene studies, and we have seen the publication of two whole-genome association analyses. The 'hypothesis free' whole-genome studies have provided additional evidence in support of a number of existing susceptibility genes and have identified novel gene candidates. In this article, we review the current SLE genetics literature in the light of these recent advances and we discuss our current understanding of the functional role of the key susceptibility genes. By considering how these genes fall into clusters with shared function we can begin to understand how dysregulation at a number of key immunological steps may predispose to the development of SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18611920     DOI: 10.1093/rheumatology/ken247

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  42 in total

1.  Identification and characterization of a lupus suppressor 129 locus on chromosome 3.

Authors:  Francesco Carlucci; Liliane Fossati-Jimack; Ingrid E Dumitriu; Yasin Heidari; Mark J Walport; Marta Szajna; Paramita Baruah; Oliver A Garden; H Terence Cook; Marina Botto
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

2.  Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus.

Authors:  Samira Alesaeidi; Jafar Karami; Mahdi Mahmoudi; Mahmoud Akbarian; Shiva Poursani; Azadeh Amirzadeh; Nazgol-Sadat Haddadi; Elahe Saffari; Ahmad Reza Jamshidi
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

3.  Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients.

Authors:  Nadine Glesse; Paula Rohr; Odirlei André Monticielo; Tássia Flores Rech; João Carlos Tavares Brenol; Ricardo Machado Xavier; Kátia Kvitko; José Artur Bogo Chies
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

4.  A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus.

Authors:  Alexandros P Grammatikos; Vasileios C Kyttaris; Katalin Kis-Toth; Lisa M Fitzgerald; Amy Devlin; Michele D Finnell; George C Tsokos
Journal:  Clin Immunol       Date:  2013-12-16       Impact factor: 3.969

Review 5.  DNA methylation alterations in the pathogenesis of lupus.

Authors:  S H Chen; Q L Lv; L Hu; M J Peng; G H Wang; B Sun
Journal:  Clin Exp Immunol       Date:  2016-11-01       Impact factor: 4.330

6.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

7.  A single-nucleotide polymorphism of the TNFSF4 gene is associated with systemic lupus erythematosus in Chinese Han population.

Authors:  Sheng-Quan Zhang; Jian-Wen Han; Liang-Dan Sun; Wen-Sheng Lu; Xian-Yong Yin; Xue-Jun Zhang; Sen Yang
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

8.  Identification of new SLE-associated genes with a two-step Bayesian study design.

Authors:  D L Armstrong; A Reiff; B L Myones; F P Quismorio; M Klein-Gitelman; D McCurdy; L Wagner-Weiner; E Silverman; J O Ojwang; K M Kaufman; J A Kelly; J T Merrill; J B Harley; S-C Bae; T J Vyse; G S Gilkeson; P M Gaffney; K L Moser; C Putterman; J C Edberg; E E Brown; J Ziegler; C D Langefeld; R Zidovetzki; C O Jacob
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

9.  What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases.

Authors:  Jacqueline E Oliver; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

10.  Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study.

Authors:  Marian Suarez-Gestal; Manuel Calaza; Emöke Endreffy; Rudolf Pullmann; Josep Ordi-Ros; Gian Domenico Sebastiani; Sarka Ruzickova; Maria Jose Santos; Chryssa Papasteriades; Maurizio Marchini; Fotini N Skopouli; Ana Suarez; Francisco J Blanco; Sandra D'Alfonso; Marc Bijl; Patricia Carreira; Torsten Witte; Sergio Migliaresi; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  Arthritis Res Ther       Date:  2009-05-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.